Skip to content

Abstract 18093: Ambulatory Rhythm Monitoring After Transcatheter Aortic Valve Replacement: A Database Observational Study Using TriNetX Through May 2026

Nov 2026 · Circulation · 0 citations

Abstract

Background: Conduction abnormalities are common complications following transcatheter aortic valve replacement (TAVR). Real-world utilization of ambulatory rhythm monitoring after TAVR and its association with heart block detection needing pacemaker or ICD implantation remain poorly characterized. We evaluate ambulatory rhythm monitoring practices post-TAVR using a large multicenter electronic health record database. Methods: Using the TriNetX database through May 31, 2026, we identified adults undergoing TAVR who survived to discharge and had ≥12 months of prior healthcare data. Patients with prior pacemakers, ICDs, implantable loop recorders, or pre-existing high-grade atrioventricular block were excluded. We characterized post-TAVR ambulatory rhythm monitoring utilization and assessed rates of permanent pacemaker/ICD implantation within 30 days and conduction abnormality detection within 30-90 days. Results: Among 42,398 adults undergoing TAVR who met eligibility criteria, ambulatory rhythm monitoring was used in a minority of patients. The most commonly utilized modalities were mobile cardiac telemetry (9.4%, n=3,971), patient-activated event monitors (8.7%, n=3,697), and 8-14-day patch monitors (7.8%, n=3,148), followed by 24-48-hour Holter monitors (6.7%, n=2,642) and extended (>48-hour-7-day) patch monitors (4.0%, n=1,614). Implantable loop recorders were used least frequently (1.5%, n=628).Within 30 days of TAVR, permanent pacemaker or ICD implantation occurred in 7.2% of patients monitored with 24-48-hour Holter devices, 6.7% with extended patch monitors, 5.4% with event monitors, 5.3% with 8-14-day patch monitors, 4.3% with mobile cardiac telemetry, and 4.2% with implantable loop recorders. Documented conduction abnormalities within 30-90 days post-TAVR were most frequently identified among implantable loop recorder recipients (42.1%), followed by extended patch monitors (39.6%), 24-48-hour Holters (39.2%), event monitors (37.0%), 8-14-day patch monitors (36.0%), and mobile cardiac telemetry (28.8%). Conclusions: Ambulatory rhythm monitoring after TAVR remains underutilized despite the high burden of post-procedural conduction disturbances. More intensive monitoring, particularly implantable loop recorders and extended patch monitors, was associated with greater detection of clinically significant abnormalities. These findings demonstrate substantial variability in post-TAVR surveillance and support further study to define optimal monitoring strategies for early arrhythmia and conduction disease detection.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.